The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy
Heming Lu,Yuying Wu,Xu Liu,Huixian Huang,Hailan Jiang,Chaohua Zhu,Yuping Man,Pei Liu,Xianglong Li,Zhaohong Chen,Xianfeng Long,Qiang Pang,Shan Deng,Junzhao Gu
DOI: https://doi.org/10.2147/CMAR.S314289
2021-08-04
Cancer Management and Research
Abstract:Heming Lu, 1, &ast Yuying Wu, 2, &ast Xu Liu, 1 Huixian Huang, 1 Hailan Jiang, 1 Chaohua Zhu, 1 Yuping Man, 3 Pei Liu, 4 Xianglong Li, 1 Zhaohong Chen, 1 Xianfeng Long, 1 Qiang Pang, 1 Shan Deng, 1 Junzhao Gu 1 1 Department of Radiation Oncology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China; 2 Department of Gynecology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China; 3 Department of Radiology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China; 4 Department of Oncology, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Heming Lu Department of Radiation Oncology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6 Taoyuan Road, Nanning, 530021, People's Republic of China Tel +86-771-218-6806 Email Purpose: To evaluate the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting early treatment response. Materials and Methods: Patients with locally advanced cervical cancer (LACC) treated with concurrent chemoradiotherapy (CCRT) were enrolled. Pelvic DCE-MRI scans were performed before RT (pre-RT), in the middle of RT (mid-RT), and at the end of RT (post-RT), separately. Parameters (ie, K trans , K ep , and V e ) were measured. Pre-, mid-, and post-RT K trans were denoted as K trans -preTx, K trans -midTx, and K trans -postTx, respectively. And the same denoting rule also went for K ep and V e . Difference for the same parameter such as K trans measured between two consecutive time points was calculated as second K trans value minus first K trans value. The differences in K trans between pre-RT and post-RT, between pre-RT and mid-RT, and between mid-RT and post-RT were denoted as ΔK trans -post-preTx, ΔK trans -mid-preTx, and ΔK trans -post-midTx, respectively, and the same denoting rule was also applied to K ep and V e . Results: A total of 57 patients were enrolled. After the treatment, 31 patients had complete response (CR group). The remaining 26 patients had partial response (NCR group). Significant differences were found in K trans -postTx, K ep- postTx, V e- midTx, ΔK trans -post-preTx, ΔK trans -post-midTx, ΔK ep- post-preTx, ΔK ep- mid-preTx and ΔK ep- post-midTx between the two groups. Receiver operating characteristic (ROC) analysis for their performances in predicting treatment response showed an area under curve (AUC) of 0.656– 0.849, sensitivity of 61.3– 93.5%, specificity of 46.1– 73.1%, and maximal Youden Index of 36.5– 66.6. Among those parameters, K ep- postTx was the best, and its AUC, sensitivity, specificity, maximal Youden Index, and cutoff value were 0.849, 87.1%, 73.1%, 60.2, and 0.341, respectively. These combined parameters showed an AUC of 0.952, with sensitivity of 87.1%, specificity of 96.1%, and maximal Youden Index of 83.2. Conclusion: DCE-MRI parameters can predict early treatment outcome. Among those parameters, K ep- postTx is the best predictor. The combination of multi-parameters can increase the predictive potency. Keywords: cervical cancer, locally advanced disease, dynamic contrast-enhanced magnetic resonance imaging, concurrent chemoradiotherapy, prognosis prediction Cervical cancer is one of the most common malignancies for females. Worldwide, the incidence of cervical cancer is ranked as the fourth disease among female malignancies, with new cases of about 530,000 and 270,000 deaths annually. Approximately, 85% of cervical cancer patients are found in less developed and developing countries, and countries with low-income and moderate-income, the mortality rate is 18 times higher than that in rich countries. 1 , 2 In the management of cervical cancer, early assessment and prediction of treatment response may facilitate the modification of treatment strategy in order to improve treatment outcome and minimize side effects. A retrospective study conducted by Li and colleagues found that in cervical cancer patients treated with neoadjuvant chemotherapy, responders had a significantly higher disease-free survival than non-responders, and both univariable and mult -Abstract Truncated-
oncology